Results 191 to 200 of about 141,900 (251)
Some of the next articles are maybe not open access.
Letrozole Compared With Clomiphene Citrate for Polycystic Ovarian Syndrome
Obstetrics and Gynecology, 2023Letrozole was associated with improved pregnancy outcomes in women with infertility and polycystic ovarian syndrome compared with clomiphene citrate.
Zhuo Liu +6 more
semanticscholar +1 more source
Clomiphene citrate for men with hypogonadism: a systematic review and meta‐analysis
Andrology, 2021Male hypogonadism is a clinical and biochemical androgen insufficiency syndrome, becoming more prevalent with age. Exogenous testosterone is first‐choice therapy, with several side effects, including negative feedback of the hypothalamic–pituitary ...
M. Huijben +4 more
semanticscholar +1 more source
International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2020
To compare the efficacy of letrozole and clomiphene citrate (CC) for ovulation induction in infertile women with polycystic ovarian syndrome (PCOS).
Shavina Bansal +3 more
semanticscholar +1 more source
To compare the efficacy of letrozole and clomiphene citrate (CC) for ovulation induction in infertile women with polycystic ovarian syndrome (PCOS).
Shavina Bansal +3 more
semanticscholar +1 more source
The effect of clomiphene citrate on oxidative stress parameters in polycystic ovarian syndrome
Journal of Obstetrics and Gynaecology Research, 2020This study aimed to examine the possible association between the oxidative stress parameters and clomiphene citrate resistance in polycystic ovary syndrome.
Nurullah Peker +5 more
semanticscholar +1 more source
The journal of obstetrics and gynaecology research, 2020
To evaluate the effect of vitamin E on ovulation and pregnancy in women with clomiphene citrate (CC)‐resistant polycystic ovary syndrome (PCOS).
A. Morsy +4 more
semanticscholar +1 more source
To evaluate the effect of vitamin E on ovulation and pregnancy in women with clomiphene citrate (CC)‐resistant polycystic ovary syndrome (PCOS).
A. Morsy +4 more
semanticscholar +1 more source
Clinical Endocrinology, 2020
Clomiphene citrate (CC) has been shown to restore the hypothalamic‐pituitary‐gonadal (HPG) axis by increasing testosterone (T) levels to physiological levels in patients with dysmetabolic conditions such as obesity, metabolic syndrome and type 2 diabetes
C. Pelusi +10 more
semanticscholar +1 more source
Clomiphene citrate (CC) has been shown to restore the hypothalamic‐pituitary‐gonadal (HPG) axis by increasing testosterone (T) levels to physiological levels in patients with dysmetabolic conditions such as obesity, metabolic syndrome and type 2 diabetes
C. Pelusi +10 more
semanticscholar +1 more source
Clomiphene Citrate for the Treatment of Hypogonadism.
Sexual Medicine Reviews, 2019INTRODUCTION Clomiphene citrate (CC) is a selective estrogen receptor modulator that has been used for the treatment of hypogonadism in men since the 1970s.
K. Wheeler +4 more
semanticscholar +1 more source
LONG TERM SAFETY AND EFFICACY OF CLOMIPHENE CITRATE FOR THE TREATMENT OF HYPOGONADISM.
Journal of Urology, 2019PURPOSE Clomiphene citrate (CC) may be used as an off-label treatment for hypogonadism. There is little long-term data on the efficacy and safety of CC when administered for over three years.
S. Krzastek +11 more
semanticscholar +1 more source
Clomiphene Citrate and Pregnancy Outcome
Australian and New Zealand Journal of Obstetrics and Gynaecology, 1994Summary: Data from Australia and elsewhere have shown consistently that adverse perinatal outcomes such as preterm birth and perinatal mortality are more common in pregnancies resulting from assisted conception with IVF and GIFT than normally conceived pregnancies.
A, Venn, J, Lumley
openaire +2 more sources